NET PROFIT (x1000 SEK)
EMPLOYEES
Sophion Bioscience A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2020/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
53,615
|
83,511
|
43,157 |
| Total assets |
300,329
|
333,164
|
189,049 |
| Current assets |
216,349
|
259,652
|
119,444 |
| Current liabilities |
51,687
|
43,148
|
44,054 |
| Equity capital |
233,674
|
281,557
|
143,646 |
| - share capital |
74,441
|
74,824
|
67,462 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Solvency |
77.8%
|
84.5%
|
76.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
418.6%
|
601.8%
|
271.1% |
| Return on equity (ROE) |
22.9%
|
29.7%
|
30.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.